发明名称 |
Particle size reduction of an antimuscarinic compound |
摘要 |
A stable crystalline micronized particulate of a glycopyrronium salt may be prepared by suspending the drug in a water-immiscible anti-solvent in which the drug has little or no solubility and micronizing the suspension. The resulting drug particles are physically stable with regard to agglomeration and/or aggregation on storage. |
申请公布号 |
US9393202(B2) |
申请公布日期 |
2016.07.19 |
申请号 |
US201414258147 |
申请日期 |
2014.04.22 |
申请人 |
CHIESI FARMACEUTICI S.p.A |
发明人 |
Pasquali Irene;Casazza Andrea;Losi Elena;Saunders Mark |
分类号 |
A61K9/16;A61K31/40;A61K9/00;A61K9/14 |
主分类号 |
A61K9/16 |
代理机构 |
Oblon, McClelland, Maier & Neustadt, L.L.P |
代理人 |
Oblon, McClelland, Maier & Neustadt, L.L.P |
主权项 |
1. A process for preparing micronized particles of a pharmaceutically acceptable salt of glycopyrronium, said process comprising:
feeding an anti-solvent, which is a water-immiscible hydrocarbon or derivative thereof which is liquid at room temperature and pressure, and has a dielectric constant lower than 15 and a density of 1.3 to 2 g/cm3 to a micronization chamber of a wet milling apparatus, which optionally contains a grinding medium; suspending particles of the glycopyrronium salt in said anti-solvent, to obtain suspended particles; micronizing said suspended particles at a pressure equal to or lower than 200 kPa, to obtain micronized particle; and optionally, drying said micronized particles, whereby at least 90% of said micronized particles have a diameter of less than 10 microns. |
地址 |
Parma IT |